Text of Kim Nye's Statement on Rare Diseases and Changing CIRM Priorities

Here is the text of the statement by Kim Nye, founder and executive director of the TESS Research Foundation, that she delivered to the board of the California Institute for Regenerative Medicine (CIRM). See this article — $3.9 Billion Left for California's Stem Cell and Gene Therapy Program; What Will it Finance? — for more about the priority review …